NewGenIvf Group (NIVF) appoints four independent directors to its Board

Rhea-AI Filing Summary

NewGenIvf Group Limited has expanded its Board by appointing four new independent directors. Ms. Lee Sze Mun joined as an independent director effective June 1, 2026, bringing over 22 years of experience in financial accounting, taxation, and group consolidation.

Mr. Lau Tsz Hin Vincent, Mr. Lam Chun Tung Patrick, and Mr. Cheung Kong Yiu were each appointed as independent directors effective June 8, 2026. The new directors contribute backgrounds in finance, risk management, digital assets, quantitative trading, and technology entrepreneurship, broadening the Board’s mix of skills and industry experience.

Key Figures

Independent directors appointed: 4 directors Effective date Ms. Lee: June 1, 2026 Effective date other directors: June 8, 2026 +2 more

5 metrics

Independent directors appointed 4 directors Board appointments disclosed in Form 6-K

Effective date Ms. Lee June 1, 2026 Start of Ms. Lee’s independent director role

Effective date other directors June 8, 2026 Start of roles for Mr. Lau, Mr. Lam, Mr. Cheung

Experience of Ms. Lee Over 22 years Financial accounting, taxation, group consolidation

Form type Form 6-K Report of foreign private issuer

Key Terms

Form 6-K, foreign private issuer, independent director, Form 20-F, +1 more

5 terms

Form 6-K regulatory

"Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16"

A Form 6-K is a report that companies listed in certain countries file to provide important updates, such as financial results, corporate changes, or other significant information, to regulators and investors. It functions like an official company update or news release, helping investors stay informed about developments that could affect their investment decisions.

foreign private issuer regulatory

"REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16"

A foreign private issuer is a company organized outside the United States that meets tests showing it is primarily foreign-controlled and therefore qualifies for a different set of U.S. reporting rules. For investors, that means the company files less frequent or differently formatted disclosures with U.S. regulators and may follow home-country accounting and governance practices, so buying its stock is like dining at a well-reviewed restaurant that follows its home kitchen’s rules instead of the local menu — you get access but should check what standards apply.

independent director financial

"announces the appointments of ... as independent directors to its Board of Directors"

An independent director is a member of a company's board of directors who is not involved in the company's day-to-day operations and has no significant relationships with the company that could influence their judgment. Their role is to provide unbiased oversight and ensure the company is managed in the best interests of all shareholders. This helps build trust and confidence among investors by promoting transparency and accountability.

Form 20-F regulatory

"whether the registrant files or will file annual reports under cover Form 20-F"

Form 20-F is the standardized annual disclosure that non-U.S. companies must file with the U.S. securities regulator when their shares are traded in the U.S.; it contains audited financial statements, a plain-language description of the business, management discussion, governance details and key risk factors. It matters to investors because it provides a consistent, comparable company “report card” and rulebook, helping buyers assess financial health, governance and risks before investing.

Board of Directors financial

"appointments of ... as independent directors to its Board of Directors"

The Board of Directors is a group of people chosen by a company's owners to help make big decisions and oversee how the company is run. They act like a team of advisors or managers, making sure the company stays on track and meets its goals. Their choices can influence the company's success and how it grows.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 6-K: How Foreign Companies Report to the SEC →

Available on EDGAR 06/11/2026 - 08:30 AM Accepted by SEC EDGAR 06/11/2026 - 08:30 AM Learn about SEC filing dates

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

For the month of June 2026

Commission File Number: 001-42004

NEWGENIVF GROUP LIMITED

36/39-36/40, 13th Floor, PS Tower

Sukhumvit 21 Road (Asoke)

Khlong Toei Nuea Sub-district

Watthana District, Bangkok 10110

Thailand

(Address of Principal Executive Offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒         Form 40-F ☐

EXPLANATORY NOTE

NewGenIvf Group Limited (the “Company”) hereby announces the appointments of Ms. Lee Sze Mun, Mr. Lau Tsz Hin Vincent, Mr. Lam Chun Tung Patrick, and Mr. Cheung Kong Yiu as independent directors to its Board of Directors. Ms. Lee Sze Mun’s appointment took effect as of June 1, 2026, and Mr. Lau Tsz Hin Vincent’s, Mr. Lam Chun Tung Patrick’s, and Mr. Cheung Kong Yiu’s appointments took effect as of June 8, 2026.

Each independent director’s biography is set out below:

Lee Sze Mun

Ms. Lee has served as an independent director of NewGenIvf since June 1, 2026. With over 22 years of experience in financial accounting, taxation, and group consolidation, she is a Fellow Member of ACCA (FCCA) and holds a BA (Hons) in Accounting and Finance from Leeds Beckett University (formerly Leeds Metropolitan University). Ms. Lee currently serves as Assistant Manager (Finance Control) at a statutory body responsible for regulating and overseeing retirement schemes. Her previous experience includes senior finance roles at a construction company that primarily undertakes government projects, as well as at a German-based multinational shipowner. She also brings audit assurance experience gained from working at a registered CPA firm.

Lau Tsz Hin Vincent

Mr. Lau has served as NewGenIvf’s independent director since June 8, 2026. Since 2025, he has served as Co-Founder and Chief Operating Officer of K25.ai. From 2024 to 2025, he served as Vice President, Business Strategy Office at OSL Group. From 2019 to 2023, he served at OKEx, Bitfinex and Digital Vision Brands. Mr. Lau holds a Bachelor of Business Administration.

Lam Chun Tung Patrick

Mr. Lam has served as NewGenIvf’s independent director since June 8, 2026. Since 2025, he has served as Co-Founder and Chief Strategy Officer of K25.ai. From 2023 to 2025, he served as a Quantitative Trader at Keyrock S.A. From 2020 to 2022, he served at HKEX across listed issuer regulation, strategy and data governance. Mr. Lam holds a Bachelor of Science in Risk Management and Business Intelligence.

Cheung Kong Yiu

Mr. Cheung has served as NewGenIvf’s independent director since June 8, 2026. Since 2024, he has served as Founder and Chief Executive Officer of K25.ai. From 2025 to 2026, he served as a Board Member of Prenetics Global Limited. From 2017 to 2020, he served as Chief Operating Officer of OKEx. Earlier in his career, he held senior leadership roles at iClick Interactive and Groupon. Mr. Cheung holds a Bachelor of Information Technology.

1

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: June 11, 2026

	NewGenIvf Group Limited
	By:	/s/ Wing Fung Alfred Siu
	Name:	Wing Fung Alfred Siu
	Title:	Chairman of the Board and Director

2

FAQ

What change did NewGenIvf Group Limited (NIVF) report in this Form 6-K?

NewGenIvf Group Limited reported the appointment of four new independent directors to its Board. The company detailed their effective appointment dates and professional backgrounds, emphasizing experience in finance, risk management, digital assets, and technology leadership.

Who are the new independent directors appointed by NewGenIvf Group Limited (NIVF)?

The new independent directors are Ms. Lee Sze Mun, Mr. Lau Tsz Hin Vincent, Mr. Lam Chun Tung Patrick, and Mr. Cheung Kong Yiu. Each brings distinct experience across accounting, financial control, digital asset businesses, quantitative trading, and technology-focused entrepreneurship roles.

When did the new independent director appointments at NewGenIvf (NIVF) become effective?

Ms. Lee Sze Mun’s appointment became effective on June 1, 2026. The appointments of Mr. Lau Tsz Hin Vincent, Mr. Lam Chun Tung Patrick, and Mr. Cheung Kong Yiu became effective on June 8, 2026, as disclosed in the report.

What experience does Ms. Lee Sze Mun bring to NewGenIvf (NIVF)’s Board?

Ms. Lee Sze Mun brings over 22 years of experience in financial accounting, taxation, and group consolidation. She is a Fellow Member of ACCA, holds a BA (Hons) in Accounting and Finance, and serves as Assistant Manager (Finance Control) at a retirement schemes regulator.

What are the professional backgrounds of the three male independent directors at NewGenIvf (NIVF)?

Mr. Lau is Co-Founder and COO of K25.ai with prior roles in digital asset firms. Mr. Lam is Co-Founder and Chief Strategy Officer of K25.ai and has quantitative trading and exchange experience. Mr. Cheung is Founder and CEO of K25.ai with prior senior positions at OKEx, iClick, and Groupon.

What SEC form did NewGenIvf Group Limited (NIVF) use for these Board changes?

NewGenIvf Group Limited used a Form 6-K, which is a report of a foreign private issuer. The filing disclosed the appointments of four independent directors and confirmed that the company files its annual reports under cover of Form 20-F.